Mariecar Jara-Puyod, Senior Reporter
The Ministry of Health and Prevention (MoHaP) on Wednesday inaugurated the Regenerative Medicine Centre at the Al Qassimi Hospital in Sharjah, boosting the UAE’s prioritisation of the health and wellness of its approximately 10 million residents. It is MoHaP’s “first-of-its-kind centre” with its licensed medical team and allied professionals having so far invented a technique for the standard management of complex wounds.
“The new Regenerative Medicine Centre at Al Qassimi Hospital is a qualitative addition to our outstanding medical edifices spread across the country,” said Emirates Health Services Corporation director general Dr. Youssif Al Serkal.
He also said: “This is part of our ongoing plans to fulfil the health requirements of community members, as well as our strategy to expand our specialised clinics’ networks and equip them with world-class medical devices and competent cadres.”
READ MORE
Global coronavirus cases surpass 100 million
Australia records 10th day of no local COVID-19 cases
A branch of medicine brought to the fore 22 years back or in 1999, Regenerative Medicine is doing away with prescriptive drugs as it is the study and application of technology and modalities such as tissue engineering, cell transplantation and stem cell therapy that permit the renewal and restoration of damaged tissues and organs.
According to the website of the Perioperative & Regenerative Acute Pain Therapies through an article published on Feb.6, 2018, “Regenerative Medicine is a promising medical field that is used to treat a range of diseases and conditions including chronic pain. Platelet rich plasma, growth factors and stem cell therapy are currently used to treat chronic pain in several joint areas including the hip, knee, ankle, wrist, elbow and shoulder,” doing away with prescriptions. The benefits are enhanced healing and reduced pain as it approaches the root cause of the illness or disease; increased functioning as the affected tissues and organs are re-strengthened; faster recovery; and reduced risk for future injuries and pain.
The new Regenerative Medicine Centre is manned by a registered and licensed qualified medical team and allied professionals trained to utilise state-of-the-art medical equipment and devices.
From the plasma and a hyperbaric oxygen therapy to the SVF Treatment, the ministry’s first-of-its kind Regenerative Medicine facility includes a unit equipped with smart bandages and Four-Dimensional (4D) Bioprinting for self-adipose tissue printing.
Al Serkal said the establishment of the new centre within the hospital is a “paradigm shift” towards enhancing and improving services: “Thanks to the presence of a highly-competent multi-disciplinary team, the availability of all capability, resources, and technology infrastructure, in addition to international partnerships with long-established medical organisations to encourage scientific research.”
In citing the competitiveness of the centre’s personnel, Al Serkal mentioned the MoHaP launch of the Dr. Invivo 4D Bioprinting Technology. This provides the latest treatment against diabetic and chronic wounds including burn injuries.
MoHaP-Hospitals Administration director Dr. Kalthoum Al Baloushi said the the centre is important as Regenerative Medicine has a substantial role in the treatment of knee and nervous system and urinate track challenges, apart from wounds and burns.
Al Qassimi Hospital Deputy Technical director/Department of Plastic, Reconstructive and Burns head Dr. Saqr Al Mualla highlighted an achievement of the centre’s medical team and that is the development of a laser wound therapy, a five-point laser technique as standard management for complex wounds.